Vaginal CO2 Laser and the Genitourinary Syndrome of Menopause

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This study evaluates the clinical, histopathological, cytological and microbiological efficacy of Microablative Fractional CO2 laser intravaginally administered in postmenopausal women with Genitourinary Syndrome of Menopause. Half participants will receive active CO2 laser therapy, while the other half will receive placebo CO2 laser therapy.
Epistemonikos ID: 8ece12d3fcb402d0315ad9f13d9265b805d6a7b9
First added on: May 21, 2024